Here is What Hedge Funds Think About Affymax, Inc. (AFFY)
In the eyes of most market participants, hedge funds are perceived as slow, outdated investment vehicles of the past.
Posts Tagged ‘NASDAQ:AFFY’
Affymax, Inc. (AFFY), Coinstar, Inc. (CSTR): The NASDAQ Composite (.IXIC)’s Five Most Hated Stocks
Short-sellers certainly huffed and puffed with all of their might in May, but it wasn't meant to be: The tech-heavy NASDAQ Composite (INDEXNASDAQ:.IXIC) rose another 3.8%, extending...
Hedge Funds Are Selling Affymax, Inc. (AFFY) – Northwest Biotherapeutics, Inc (NWBO), Celsion Corporation (CLSN)
In today’s marketplace, there are many metrics investors can use to watch Mr. Market. A couple of the most under-the-radar are hedge fund and insider trading interest.
ZIOPHARM Oncology Inc. (ZIOP), Ariad Pharmaceuticals, Inc. (ARIA): 3 Reasons Investors Are Scared of Biotech Stocks
Biotechs offer the possibility of monster returns. Overnight doubles aren't out of the question.
Amgen, Inc. (AMGN), Affymax, Inc. (AFFY): The Danger of the One-Hit Wonder
The drug development field is a potentially lucrative, although always dangerous area for small companies and their investors to participate in.
3 Can’t-Miss Health-Care Events This Week: Synageva BioPharma Corp (GEVA), Amedisys Inc (AMED), Gentiva Health Services, Inc. (GTIV)
You won't often hear me say this, but it's a pretty quiet week on the health-care front.
This Week in Biotech: Dynavax Technologies Corporation (DVAX), Zogenix, Inc. (ZGNX)
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Stocks That May Help Determine the Dow’s Moves Today: Affymax, Inc. (AFFY) and More
The Dow Jones Industrial Average finished strong last week, and eked out a closing price just above the 14,000 mark.
Behold the Dangers of a One-Trick Pony: Affymax, Inc. (AFFY) and More
At the end of last year, I proclaimed Omontys -- an erythropoiesis-stimulating agent, or ESA, that aids in the formation of red blood cells -- as one of my 10 drugs approved by...
Down 85%! Why Affymax, Inc. (AFFY) is Getting Crushed This Morning
Look out below Affymax, Inc. (NASDAQ:AFFY) investors.
Dow Jones Industrial Average (.DJI)’s Bumpy Ride Keeps It in Positive Territory
The Dow Jones Industrial Average (INDEX:.DJI) has had a wild ride this morning, but stayed up nevertheless.
Affymax, Inc. (AFFY) Hit Hard… and Then Rebounds?
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
5 Health Care Stocks Slumping in 2013: NPS Pharmaceuticals, Inc. (NPSP), OraSure Technologies, Inc. (OSUR)
Stocks are rolling along unchallenged, surging to highs not seen since 2007.
Has Amgen, Inc. (AMGN) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
What’s Next for Affymax, Inc. (AFFY)?
Affymax, Inc. (NASDAQ:AFFY) received its first Food and Drug Administration approval last spring with Omontys for anemia in dialysis patients.
